skip to content

Department of Oncology


The Cancer Research UK Cambridge Centre has been awarded around £22.5 million over the next five years for their ground-breaking work, as part of the development of a unique chain of cutting-edge research hubs around the UK.

The money will be used to accelerate work into diagnosing a wide range of cancers in children and adults at a much earlier stage, including pancreatic, ovarian and children’s cancers.

The funding will support the development of the Centre’s Advanced Imaging capability, enabling scientists to look inside cancer cells in more detail than ever before and find the physical features that could be vulnerable to new treatments.

Professor Richard Gilbertson, Director at the Cancer Research UK Cambridge Centre and Head of Department of Oncology, said:

“We’ve had a challenging year and COVID-19 has slowed us down. But we will not stop working hard to find new treatments for cancer, and this investment will give us the tools we need to deliver high quality research that will make the biggest difference for patients.

“This investment means we will be able to further develop our work in translational research – getting cutting-edge discoveries from the laboratory to patients and learning as much as possible from patients to initiate new research.”

Cambridge has been chosen as one of just seven locations(link is external) to secure funding in the latest review of the Cancer Research UK Centres network of excellence. These are world-class research centres that draw together leading research and medical expertise to drive the best possible results for cancer patients.

Every year around 37,300 people are diagnosed with cancer in the East of England.